Khaitan & Co advised Torrent Pharmaceuticals Limited (“Torrent Pharma”) in relation to its acquisition of the domestic formulations business of Unichem Laboratories Limited through a business transfer arrangement for INR 3600 crores ($556m approximately). Torrent Pharma, the flagship company of Torrent Group, is ranked amongst the top pharma companies in India. It is a dominant player in the therapeutic areas of cardiovascular (CV) and central nervous system (CNS) and has achieved significant presence in gastrointestinal, diabetology, anti-infective and pain management segments. Core transaction team: Led by Bhavik Narsana (Partner) along with the core team comprising of Minhaz Lokhandwala (senior associate) and Shreya Mukherjee (associate). Shailendra Bhandare (counsel) advised on the intellectual property rights related aspects.